M. Iotti

1.2k total citations · 1 hit paper
9 papers, 834 citations indexed

About

M. Iotti is a scholar working on Internal Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Iotti has authored 9 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Internal Medicine, 5 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Iotti's work include Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Diagnosis and Treatment of Venous Diseases (3 papers). M. Iotti is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Diagnosis and Treatment of Venous Diseases (3 papers). M. Iotti collaborates with scholars based in Italy, Switzerland and Netherlands. M. Iotti's co-authors include Angelo Ghirarduzzi, Raffaele Pesavento, Vittorio Pengo, Antonio Pagnan, Enrico Bernardi, Franco Noventa, Paolo Simioni, Daniela Tormene, Paolo Prandoni and Paolo Prandoni and has published in prestigious journals such as BMJ, Journal of Thrombosis and Haemostasis and Haematologica.

In The Last Decade

M. Iotti

9 papers receiving 811 citations

Hit Papers

The risk of recurrent venous thromboembolism after discon... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Iotti Italy 7 706 535 274 238 102 9 834
Lelia Valdré Italy 11 363 0.5× 241 0.5× 338 1.2× 167 0.7× 57 0.6× 22 584
Ida Ehlers Albertsen Denmark 13 321 0.5× 409 0.8× 51 0.2× 116 0.5× 51 0.5× 29 580
Ralph George United States 4 495 0.7× 389 0.7× 134 0.5× 298 1.3× 80 0.8× 5 641
András Vorobcsuk Hungary 13 203 0.3× 593 1.1× 35 0.1× 253 1.1× 37 0.4× 24 757
Katia Paciaroni Italy 4 467 0.7× 312 0.6× 610 2.2× 77 0.3× 11 0.1× 5 728
Ron Peters Netherlands 9 281 0.4× 403 0.8× 111 0.4× 262 1.1× 6 0.1× 20 614
Thure Filskov Overvad Denmark 18 399 0.6× 986 1.8× 37 0.1× 106 0.4× 50 0.5× 51 1.2k
A. Šrámek Netherlands 9 154 0.2× 157 0.3× 349 1.3× 95 0.4× 14 0.1× 14 533
Sven Pannach Germany 9 362 0.5× 509 1.0× 58 0.2× 82 0.3× 9 0.1× 11 608
Nebojša Antonijević Serbia 11 123 0.2× 191 0.4× 145 0.5× 68 0.3× 6 0.1× 65 430

Countries citing papers authored by M. Iotti

Since Specialization
Citations

This map shows the geographic impact of M. Iotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Iotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Iotti more than expected).

Fields of papers citing papers by M. Iotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Iotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Iotti. The network helps show where M. Iotti may publish in the future.

Co-authorship network of co-authors of M. Iotti

This figure shows the co-authorship network connecting the top 25 collaborators of M. Iotti. A scholar is included among the top collaborators of M. Iotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Iotti. M. Iotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sartori, Michelangelo, M. Iotti, Giuseppe Camporese, et al.. (2024). Six‐week low‐molecular‐weight heparin versus 12‐week warfarin for calf deep vein thrombosis: A randomized, prospective, open‐label study. American Journal of Hematology. 99(5). 854–861. 2 indexed citations
2.
Ageno, Walter, Lorenza Bertù, Eugenio Bucherini, et al.. (2022). Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ. 379. e072623–e072623. 22 indexed citations
3.
Riva, Nicoletta, Giuseppe Camporese, M. Iotti, et al.. (2017). Age‐adjusted D‐dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm. Journal of Thrombosis and Haemostasis. 16(2). 271–278. 22 indexed citations
4.
Sartori, Michelangelo, Elisabetta Favaretto, Ludovica Migliaccio, et al.. (2016). Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment. European Journal of Vascular and Endovascular Surgery. 52(5). 658–664. 14 indexed citations
6.
Prandoni, Paolo, Franco Noventa, Angelo Ghirarduzzi, et al.. (2007). The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 92(2). 199–205. 550 indexed citations breakdown →
7.
Prandoni, Paolo, Angelo Ghirarduzzi, Martin H. Prins, et al.. (2006). Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. Journal of Thrombosis and Haemostasis. 4(9). 1891–1896. 141 indexed citations
8.
Lugari, R, D. Ugolotti, Alessandra Dei, et al.. (2001). Urinary Excretion of Glucagon-Like Peptide 1 (GLP-1) 7-36 Amide in Human Type 2 (Non-Insulin-Dependent) Diabetes Mellitus. Hormone and Metabolic Research. 33(9). 568–571. 2 indexed citations
9.
Lugari, R, D. Ugolotti, Alessandra Dei, et al.. (2000). Effect of Nutrient Ingestion on Glucagon-Like Peptide 1 (7-36 Amide) Secretion in Human Type 1 and Type 2 Diabetes. Hormone and Metabolic Research. 32(10). 424–428. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026